Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ceasing aLpha-blockers Early After Resection of the Prostate (The CLEAR Trial): A Multicenter, Double-blind, Placebo-controlled, Non-inferiority and Nested Superiority Randomized Clinical Trial

NCT07846579 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT07846579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07846579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ceasing aLpha-blockers Early After Resection of the Prostate (The CLEAR Trial): A Multicenter, Double-blind, Placebo-controlled, Non-inferiority and Nested Superiority Randomized Clinical Trial
Lead sponsor
Shanghai East Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
February 1, 2029
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia